Skip to main navigation Skip to search Skip to main content

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer

Research output: Contribution to journal › Journal article › Research › peer-review

Fingerprint

Dive into the research topics of 'EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer'. Together they form a unique fingerprint.
Sort by

Neuroscience

Biochemistry, Genetics and Molecular Biology